| abstract |
The use of a compound of the formula (I) as defined below or of anpharmaceutically acceptable salt thereof for the manufacture of a medicament forntreating atherosclerosis, independent of lipid lowering:-n nwherein n R 1 and R 2 may be the same or different provided that, when R 1 and R 2 arenthe same, each is a methyl or ethyl group, and, when R 1 and R 2 are different, one ofnthem is a methyl or ethyl group and the other is hydrogen or a benzyl group. |